Even With More Rejections in November, 2018 Likely to Have Lowest Number of Refusals of Shrimp Imports for Banned Antibiotics in Over a Decade

For the month of November, the U.S. Food and Drug Administration (FDA) reports that 4 out of the 61 (6.6%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics.

So far this year, there has been a total of 47 shrimp entry lines refused for reasons related to banned antibiotics. Absent a significant change in trends in December, the FDA is likely to report the smallest number of shrimp entry lines refused for banned antibiotics since 2006.

The four shrimp entry line refusals in November were from three exporters in three different countries:

The FDA also refused one entry line of shrimp from Corlim Marine Exports (India) in November due to the presence of salmonella.